|
Dr. Papastephanou joined Ortec's executive management group after spending nearly 30 years at Bristol Myers-Squibb, a multinational pharmaceutical company. For 14 years, he was with ConvaTec, the $750 million multinational Ostomy and Wound Care Management division. During his tenure at ConvaTec, in addition to having held various executive positions at the Director and Senior Vice President levels, Dr. Papastephanou was President of the $500 million global Chronic Care division. In his capacity as President, Dr. Papastephanou had direct responsibility for the P & L of the United States, Canada, and five major European markets, including sales and marketing efforts, clinical performance, and research and development.
Dr. Papastephanou was a member of ConvaTec's executive committee participating in the development and implementation of strategic initiatives and operating plans for the global business. In addition, Dr. Papastephanou had direct responsibility for the global operations of ConvaTec, including facilities, manufacturing, supply chain management, engineering, quality assurance, and regulatory affairs.
Dr. Papastephanou holds a Ph.D. in Biochemistry as well as a Master of Science in Microbial Biochemistry. | 